Publications by authors named "Daniel C Capaldi"

Claim this Profile
C
Characterization of high molecular weight impurities in synthetic phosphorothioate oligonucleotides.
Christine Kurata, Kym Bradley, Hans Gaus, Nhuy Luu, Isaiah Cedillo, Daniel C Capaldi

Bioorg Med Chem Lett· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trichloroacetaldehyde modified oligonucleotides.
Hans Gaus, Phil Olsen, Kent Van Sooy, Claus Rentel, Brett Turney, Daniel C Capaldi

Bioorg Med Chem Lett· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formation of modified cytosine residues in the presence of depurinated DNA.
Claus Rentel, Xiaojing Wang, Michael Batt, Christine Kurata, Jay Oliver, Daniel C Capaldi

J Org Chem· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formation of 4,4'-dimethoxytrityl-C-phosphonate oligonucleotides.
Daniel C Capaldi, Hans J Gaus, Recaldo L Carty, Max N Moore, Brett J Turney

Bioorg Med Chem Lett· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of high quality phosphorothioate oligonucleotides as antisense drugs. Use of I-linker in the elimination of 3'-terminal phosphorothioate monoesters.
Vasulinga T Ravikumar, R Krishna Kumar, Daniel C Capaldi, Douglas L Cole

Nucleosides Nucleotides Nucleic Acids· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antisense phosphorothioate oligodeoxyribonucleotide targeted against ICAM-1: synthetic and biological characterization of a process-related impurity formed during oligonucleotide synthesis.
Vasulinga T Ravikumar, Daniel C Capaldi, Walt F Lima, Elena Lesnik, Brett Turney

Bioorg Med Chem· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis